Management Message

In October 2013, Amgen, a biotechnology pioneer since 1980 and one of the world's leading independent biopharmaceutical companies, and Astellas Pharma, a leading Tokyo-based global pharmaceutical company, together founded Amgen Astellas BioPharma with a mission to deliver breakthrough-science-based medicines and contribute to the creation of a healthy society. Since then, we have been tirelessly striving to address unmet medical needs of patients who need innovative medicines to fight disease.

Our aspirations evolved into Amgen Astellas BioPharma’s first MHLW approved product in January 2016.  And the efforts continue to further enhance new therapeutic options for patients in Japan.

To fulfill our mission, Amgen Astellas BioPharma work in a spirit of one team to realize the following visions:

  1. Deliver breakthrough-science:
    Maximize the value of our medicines for patients and become a category leader
  2. Develop a culture that attracts top talent:
    Create opportunities for professional fulfillment and growth, where employees can be successful and proud
  3. Establish a strong partnership with stakeholders:
    Create exceptional value for patients that can only be achieved by combining the strengths of Amgen and Astellas with those of external stakeholders

At Amgen Astellas BioPharma, we are committed to developing new ways to tackle disease. The future is one of crossing new scientific frontiers, doing what we can to serve patients and advance the practice of medicine in Japan.

Mark Tennyson
General Manager and Representative
Director
Amgen Astellas BioPharma K.K.